Published in Tech Vasc Interv Radiol on December 01, 2013
Thermal Ablation of Renal Tumors: Indications, Techniques and Results. Dtsch Arztebl Int (2015) 1.19
Image-guided percutaneous renal cryoablation for stage 1 renal cell carcinoma with high surgical risk. World J Surg Oncol (2015) 0.81
Evolutionary magnetic resonance appearance of renal cell carcinoma after percutaneous cryoablation. Br J Radiol (2016) 0.75
Comparative Outcome of Computed Tomography-guided Percutaneous Radiofrequency Ablation, Partial Nephrectomy or Radical Nephrectomy in the Treatment of Stage T1 Renal Cell Carcinoma. Rare Tumors (2015) 0.75
In Reply. Dtsch Arztebl Int (2015) 0.75
Complications of ultrasound-guided percutaneous microwave ablation of renal cell carcinoma. Onco Targets Ther (2016) 0.75
Use of cryoablation beyond the prostate. Insights Imaging (2016) 0.75
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer. J Nucl Med (2012) 2.00
Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas. Am J Surg Pathol (2011) 1.76
Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy. J Urol (2012) 1.59
Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology (2002) 1.44
Case of hereditary papillary renal cell carcinoma. J Community Hosp Intern Med Perspect (2012) 1.39
Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo. Cancer Res (2006) 1.24
Renal cell carcinoma seeding of a percutaneous biopsy tract. Can Urol Assoc J (2013) 1.17
Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer. Urology (2002) 1.10
Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba. Fam Cancer (2008) 1.02
Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy. Mol Ther (2006) 1.01
Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer. Cancer Res (2002) 0.97
Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Lett (2008) 0.97
Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo. Mol Cancer Ther (2009) 0.94
A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts. Nucleic Acids Res (2012) 0.93
Androgen receptor attenuation of Ad5 replication: implications for the development of conditionally replication competent adenoviruses. Mol Ther (2007) 0.92
Safety and efficacy of CT-guided percutaneous cryoablation for renal cell carcinoma. J Vasc Interv Radiol (2008) 0.91
Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells. J Pharmacol Exp Ther (2006) 0.91
Determinants of outcomes after resection of renal cell carcinoma with venous involvement. Int Urol Nephrol (2012) 0.90
A novel method for generating and screening peptides and libraries displayed on adenovirus fiber. Nucleic Acids Res (2007) 0.90
Determination of the nonlethal margin inside the visible "ice-ball" during percutaneous cryoablation of renal tissue. Cardiovasc Intervent Radiol (2012) 0.89
Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector. Urol Oncol (2008) 0.88
A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomy. Urology (2012) 0.88
A real time Metridia luciferase based non-invasive reporter assay of mammalian cell viability and cytotoxicity via the β-actin promoter and enhancer. PLoS One (2012) 0.88
Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells. Cancer Gene Ther (2004) 0.87
Preoperative diagnosis of malignant mesothelioma of the tunica vaginalis using Doppler ultrasound. Urology (2009) 0.87
Complications of renal cryoablation: a single center experience. J Urol (2010) 0.85
Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen. Mol Cancer Ther (2004) 0.85
Mechanism of growth inhibition of prostate cancer xenografts by valproic acid. J Biomed Biotechnol (2012) 0.85
Cryoimmunotherapy in urologic oncology. Urology (2009) 0.83
Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell. Urol Int (2009) 0.82
Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablation. J Pharmacol Exp Ther (2009) 0.82
Adenovirus targeting to prostate-specific membrane antigen through virus-displayed, semirandom peptide library screening. Cancer Res (2010) 0.82
Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomas. Hum Pathol (2012) 0.81
Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer. Int J Radiat Biol (2010) 0.80
Evaluation of prostate-specific membrane antigen as an imaging reporter. J Nucl Med (2014) 0.80
Single-center comparative oncologic outcomes of surgical and percutaneous cryoablation for treatment of renal tumors. J Endourol (2012) 0.79
Biodistribution and safety assessment of bladder cancer specific recombinant oncolytic adenovirus in subcutaneous xenografts tumor model in nude mice. Curr Gene Ther (2012) 0.78
The role of lithium carbonate and lithium citrate in regulating urinary citrate level and preventing nephrolithiasis. Int J Biomed Sci (2009) 0.78
Renal function and oncologic outcomes after cryoablation or partial nephrectomy for tumors in solitary kidneys. Korean J Urol (2011) 0.78
Adenoviral gene therapy, radiation, and prostate cancer. Rev Urol (2005) 0.77
Monitoring nanoparticle-mediated cellular hyperthermia with a high-sensitivity biosensor. Nanomedicine (Lond) (2014) 0.75
Does valproic acid induce neuroendocrine differentiation in prostate cancer? J Biomed Biotechnol (2010) 0.75
Development of a research agenda for percutaneous renal tumor ablation: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol (2010) 0.75
Fat-predominant mixed epithelial stromal tumor (MEST): report of a unique case mimicking angiomyolipoma. Int J Surg Pathol (2008) 0.75
Large renal metastasis from rare pulmonary neoplasm. Urology (2010) 0.75
Gene therapy for urologic cancer. Curr Urol Rep (2002) 0.75
Incidental discovery of a renal cell carcinoma on native kidney biopsy. Am J Kidney Dis (2009) 0.75
Lentivirus-mediated p21/Waf-1 short hairpin RNA enhances the cytotoxic effects and replicative potential of a bladder cancer-specific oncolytic adenovirus in vitro. Anticancer Drugs (2017) 0.75